Pharma whistleblower feeling pretty lonely these days

The upside of blowing the whistle on what you think is wrongdoing is that you can make some serious money doing it. The downside, as Pfizer's Peter Rost is finding out, is that no one at the company wants to have anything to do with you (frankly, I would have quit if I were him). Here's a snip from the New York Times article (thanks to Debra for bringing it to my attention!):

First, his employees stopped reporting to him. Then his supervisors

stopped returning his calls and now he does not know whom to report to.

His secretary left, he said, and he was moved to an office near

Pfizer's security department at a company building in Peapack, N.J. The

latest blow came Monday, the morning after Dr. Rost, 46, appeared on a

segment of "60 Minutes" on CBS about drug prices - a follow-up to his

news conference on the subject last year with members of Congress and

to the opinion pieces he has written for The New York Times

and other newspapers. Ready, as always, to put in a full day at the

office, Dr. Rost turned on his computer Monday and tried for the first

time in almost two weeks to log into his Pfizer e-mail account.

Access denied.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.